ASTROCYTOMA CELLS HARBORING MUTANT IDH1 ARE UNIQUELY SENSITIVE TO INHIBITION OF OXIDATIVE PHOSPHORYLATION

被引：0
|
作者：
Gurjar, Anagha [1 ]
Colman, Howard [2 ]
Holmen, Sheri [1 ]
机构：
[1] Univ Utah, Huntsman Inst, Hlth Sci Ctr, Salt Lake City, UT USA
[2] Univ Utah, Huntsman Canc Inst, Dept Neurosurg, Salt Lake City, UT USA
来源：
NEURO-ONCOLOGY | 2022年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EXTH-69
引用
收藏
页码：225 / 225
页数：1
相关论文
共 50 条
  • [31] Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia
    Charu Gupta
    Stefan Kaulfuss
    Kerstin Görlich
    Basem Othman
    Anuhar Chaturvedi
    Michael Heuser
    Annals of Hematology, 2020, 99 : 1415 - 1417
  • [32] PLK1 inhibition enhances temozolomide efficacy in IDH1 mutant gliomas
    Koncar, Robert F.
    Chu, Zhengtao
    Romick-Rosendale, Lindsey E.
    Wells, SusanneI.
    Chan, Timothy A.
    Qi, Xiaoyang
    Bahassi, El Mustapha
    ONCOTARGET, 2017, 8 (09) : 15827 - 15837
  • [33] Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity
    Wu, Meng-Ju
    Kondo, Hiroshi
    Kammula, Ashwin V.
    Shi, Lei
    Xiao, Yi
    Dhiab, Sofiene
    Xu, Qin
    Slater, Chloe J.
    Avila, Omar I.
    Merritt, Joshua
    Kato, Hiroyuki
    Kattel, Prabhat
    Sussman, Jonathan
    Gritti, Ilaria
    Eccleston, Jason
    Sun, Yi
    Cho, Hyo Min
    Olander, Kira
    Katsuda, Takeshi
    Shi, Diana D.
    Savani, Milan R.
    Smith, Bailey C.
    Cleary, James M.
    Mostoslavsky, Raul
    Vijay, Vindhya
    Kitagawa, Yosuke
    Wakimoto, Hiroaki
    Jenkins, Russell W.
    Yates, Kathleen B.
    Paik, Jihye
    Tassinari, Ania
    Saatcioglu, Duygu Hatice
    Tron, Adriana E.
    Haas, Wilhelm
    Cahill, Daniel
    Mcbrayer, Samuel K.
    Manguso, Robert T.
    Bardeesy, Nabeel
    SCIENCE, 2024, 385 (6705) : eadl6173
  • [34] Heterozygous IDH1 mutations modify the citric acid (TCA) cycle metabolism and sensitize cells to inhibition of mitochondrial respiration/oxidative phosphorylation.
    Grassiani, Alexandra R.
    Parker, Seth
    Davidson, Shawn
    Green, Courtney
    Lin, Fallon
    Joud-Caldwelli, Carol
    Yin, Hong
    Chung, Franklin
    Straub, Christopher
    Vander Heiden, Matthew
    Pagliarini, Raymond
    Metallo, Christian
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [35] Metabolic addiction in IDH1 mutant cancers
    Chi, Andrew S.
    Tateishi, Kensuke
    Hiroaki, VVakimoto
    Batchelor, Tracy T.
    Lafrate, Anthony J.
    Cahill, Daniel P.
    CANCER RESEARCH, 2016, 76
  • [36] Mutant IDH1: An immunotherapeutic target in tumors
    Schumacher, Theresa
    Bunse, Lukas
    Wick, Wolfgang
    Platten, Michael
    ONCOIMMUNOLOGY, 2014, 3 (12) : 1 - 2
  • [37] THE IDH1 MUTANT INHIBITOR AG-120 SHOWS STRONG INHIBITION OF 2-HG PRODUCTION IN AN ORTHOTOPIC IDH1 MUTANT GLIOMA MODEL IN VIVO
    Nicolay, Brandon
    Narayanaswamy, Rohini
    Aguado, Elia
    Nagaraja, Raj
    Murtie, Josh
    Liu, Guowen
    Ishii, Yuko
    NEURO-ONCOLOGY, 2017, 19 : 86 - 86
  • [38] Novel IDH1 mutant inhibitors identified
    Sarah Crunkhorn
    Nature Reviews Drug Discovery, 2015, 14 (12) : 820 - 820
  • [39] Mutant IDH1 Prevents Thrombosis in Gliomas
    Horbinski, Craig
    Schwarze, Steven
    Khoury, Laith
    Thomas, Cheddhi
    Benjamin, Carolina
    Chen, Rui
    Dawson, Caleb
    Liu, Yinxing
    Song, Kristine
    Pacione, Donato
    Zagzag, David
    McIntyre, Thomas
    Snuderl, Matija
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2015, 74 (06): : 590 - 590
  • [40] Mutant IDH1 is essential for chondrosarcoma growth
    Li, Luyuan
    Hu, Xiaoyu
    Eid, Josiane E.
    DeSalvo, Joanna
    Trent, Jonathan C.
    CANCER RESEARCH, 2019, 79 (13)
12345